Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study

Tarih

Yazarlar

Celayir, Melisa

Ozyurt, Neslihan

Uluc, Basak Oyan

DOI No

10.3390/cancers16193389

Diğer Tanımlayıcı No

WOS:001331766600001

Yayınevi

Anahtar kelimeler

triple\\-negative breast cancer, neoadjuvant therapy, pembrolizumab, pathological complete response, real world, event\\-free survival, overall survival, safety

URI

https://openaccess.acibadem.edu.tr/handle/11443/5547

Koleksiyonlar

Tam öğe sayfası